{"title":"Desflurane-Induced肝炎","authors":"T. Nelson","doi":"10.5580/2b99","DOIUrl":null,"url":null,"abstract":"Inflammatory hepatitis following desflurane anesthesia was once thought to be a rare occurrence. However, case reports documenting complications related to the use of this anesthetic continue to accumulate (1-5) . Risk factors for desflurane-induced hepatitis likely exist. Female gender, prior anesthetic experience with halothane, occupational exposure to halogenated anesthetics, atopy, and autoimmune disease may predispose an individual to immunemediated hepatitis following desflurane anesthesia (6,7)","PeriodicalId":396781,"journal":{"name":"The Internet Journal of Anesthesiology","volume":"140 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Desflurane-Induced Hepatitis\",\"authors\":\"T. Nelson\",\"doi\":\"10.5580/2b99\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Inflammatory hepatitis following desflurane anesthesia was once thought to be a rare occurrence. However, case reports documenting complications related to the use of this anesthetic continue to accumulate (1-5) . Risk factors for desflurane-induced hepatitis likely exist. Female gender, prior anesthetic experience with halothane, occupational exposure to halogenated anesthetics, atopy, and autoimmune disease may predispose an individual to immunemediated hepatitis following desflurane anesthesia (6,7)\",\"PeriodicalId\":396781,\"journal\":{\"name\":\"The Internet Journal of Anesthesiology\",\"volume\":\"140 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-05-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Internet Journal of Anesthesiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5580/2b99\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Internet Journal of Anesthesiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5580/2b99","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Inflammatory hepatitis following desflurane anesthesia was once thought to be a rare occurrence. However, case reports documenting complications related to the use of this anesthetic continue to accumulate (1-5) . Risk factors for desflurane-induced hepatitis likely exist. Female gender, prior anesthetic experience with halothane, occupational exposure to halogenated anesthetics, atopy, and autoimmune disease may predispose an individual to immunemediated hepatitis following desflurane anesthesia (6,7)